Fierce Biotech

Subscribe to Fierce Biotech feed
Updated: 5 hours 41 min ago

BioCryst's voluntary pause turns FDA-hold as investigation reveals likely culprit behind safety signals

Thu, 05/05/2022 - 07:21
BioCryst's voluntary pause turns FDA-hold as investigation reveals likely culprit behind safety signals mbayer Thu, 05/05/2022 - 10:21

BD tightens up revenue guidance after completing Embecta diabetes spinoff

Thu, 05/05/2022 - 07:06
BD tightens up revenue guidance after completing Embecta diabetes spinoff chale Thu, 05/05/2022 - 10:06

Big pharma resisting temptation for biotech M&A spree until prices drop further

Thu, 05/05/2022 - 06:53
Big pharma resisting temptation for biotech M&A spree until prices drop further jwaldron Thu, 05/05/2022 - 09:53

Bavarian Nordic's COVID-19 vaccine holds up against omicron in phase 2, fueling pivotal booster push

Thu, 05/05/2022 - 05:54
Bavarian Nordic's COVID-19 vaccine holds up against omicron in phase 2, fueling pivotal booster push ntaylor Thu, 05/05/2022 - 08:54

Jazz flexes deal chops, paying Sumitomo $50M for ex-Asia rights to early-phase narcolepsy prospect

Thu, 05/05/2022 - 05:05
Jazz flexes deal chops, paying Sumitomo $50M for ex-Asia rights to early-phase narcolepsy prospect ntaylor Thu, 05/05/2022 - 08:05

Change of heart: Antibody therapy reverses 'incurable' pulmonary hypertension in mice

Wed, 05/04/2022 - 13:44
Change of heart: Antibody therapy reverses 'incurable' pulmonary hypertension in mice gmasson Wed, 05/04/2022 - 16:44

Sidekick Health nets $55M to bolster digital therapeutics programs

Wed, 05/04/2022 - 13:01
Sidekick Health nets $55M to bolster digital therapeutics programs chale Wed, 05/04/2022 - 16:01

FDA clears Abbott test to spot 4 STIs at once amid soaring case rates

Wed, 05/04/2022 - 11:46
FDA clears Abbott test to spot 4 STIs at once amid soaring case rates apark Wed, 05/04/2022 - 14:46

WCG, Deep 6 AI team up to increase speed, diversity of clinical trials

Wed, 05/04/2022 - 11:16
WCG, Deep 6 AI team up to increase speed, diversity of clinical trials mbayer Wed, 05/04/2022 - 14:16

BerGenBio shifts focus from COVID—to COVID in new business strategy update

Wed, 05/04/2022 - 10:57
BerGenBio shifts focus from COVID—to COVID in new business strategy update aarmstrong Wed, 05/04/2022 - 13:57

Curebase attracts Gilead as backer in $40M financing to expand business

Wed, 05/04/2022 - 09:51
Curebase attracts Gilead as backer in $40M financing to expand business aarmstrong Wed, 05/04/2022 - 12:51

Asia-Pacific CRO Novotech makes US play with NCGS acquisition

Wed, 05/04/2022 - 09:35
Asia-Pacific CRO Novotech makes US play with NCGS acquisition aarmstrong Wed, 05/04/2022 - 12:35

Fresenius Medical Care taps former Philips exec to take the reins after CEO's retirement

Wed, 05/04/2022 - 09:03
Fresenius Medical Care taps former Philips exec to take the reins after CEO's retirement apark Wed, 05/04/2022 - 12:03

Elligo, WHYZE join forces to break down barriers for clinical trials

Wed, 05/04/2022 - 08:58
Elligo, WHYZE join forces to break down barriers for clinical trials jwaldron Wed, 05/04/2022 - 11:58

Bancel has 'never been as busy' amid M&A talks as Moderna preps for life after COVID

Wed, 05/04/2022 - 07:41
Bancel has 'never been as busy' amid M&A talks as Moderna preps for life after COVID mbayer Wed, 05/04/2022 - 10:41

FDA approves Orthofix's ultrasonic bone fracture healing system

Wed, 05/04/2022 - 07:25
FDA approves Orthofix's ultrasonic bone fracture healing system chale Wed, 05/04/2022 - 10:25

Apnimed closes $62.5M series C after working tirelessly on lead sleep disorder drug

Wed, 05/04/2022 - 07:24
Apnimed closes $62.5M series C after working tirelessly on lead sleep disorder drug gmasson Wed, 05/04/2022 - 10:24

Siemens nearly doubles diagnostics forecast for the year amid renewed COVID testing surge

Wed, 05/04/2022 - 07:12
Siemens nearly doubles diagnostics forecast for the year amid renewed COVID testing surge apark Wed, 05/04/2022 - 10:12

Kezar scarred as midphase autoimmune blowup raises doubts about pipeline-in-a-drug vision

Wed, 05/04/2022 - 06:28
Kezar scarred as midphase autoimmune blowup raises doubts about pipeline-in-a-drug vision ntaylor Wed, 05/04/2022 - 09:28

Catalio reloads with $381M after financing Octant, Pheast

Wed, 05/04/2022 - 06:23
Catalio reloads with $381M after financing Octant, Pheast aarmstrong Wed, 05/04/2022 - 09:23